Trinity Meds GLP-1 Weight-Loss Program

Product Details

What Is Trinity Meds?

Trinity Meds is an online weight-management service that connects adults with licensed clinicians through the OpenLoop telehealth platform. The program offers medical evaluation and access to compounded injectable GLP-1 medications when a provider determines that treatment is appropriate.

The available programs currently feature compounded semaglutide and compounded tirzepatide. These are prescription medications rather than dietary supplements. The service includes remote medical review, ongoing support and home delivery from a partner pharmacy.

Who May Consider Trinity Meds?

Adults seeking professional help with weight management may consider the service when lifestyle measures alone have not provided sufficient progress. Eligibility depends on medical history, current weight, weight-related health factors, medications and the clinician’s judgment.

The program is not suitable for everyone. People with unexplained weight changes, an eating disorder, pregnancy, severe digestive problems or significant endocrine symptoms should receive a complete medical evaluation before starting prescription weight-loss treatment.

How May the Program Support Weight Management?

GLP-1 medicines act on hormone pathways involved in appetite, fullness, digestion and glucose regulation. Semaglutide works through the GLP-1 receptor, while tirzepatide works through both GIP and GLP-1 receptor pathways.

When medically appropriate, these medicines may help a patient feel satisfied with smaller portions and follow a reduced-calorie eating plan more consistently. Treatment should be combined with nutrition, physical activity and regular clinical monitoring.

Evidence from FDA-approved medications cannot automatically be applied to a compounded product. Results also depend on the prescribed formulation, dose, adherence, health history and lifestyle habits.

Medication Options

Compounded Semaglutide

Compounded semaglutide is offered as a once-weekly subcutaneous injection. Semaglutide acts on GLP-1 receptors involved in appetite, glucose-dependent insulin release and delayed gastric emptying.

The prescribed concentration and dose are determined by the treating clinician and dispensing pharmacy.

Compounded Tirzepatide

Compounded tirzepatide is also offered as a once-weekly subcutaneous injection. Tirzepatide activates GIP and GLP-1 receptors that influence appetite, glucose regulation and digestion.

The clinician determines whether it is appropriate and provides an individualized treatment plan.

How Trinity Meds Works

1. Complete the Online Assessment

Adults begin with a short online questionnaire covering weight goals, health history and possible eligibility for prescription treatment.

2. Receive a Clinical Review

An affiliated licensed provider reviews the submitted information. A telehealth consultation may be required before the provider makes a prescribing decision.

3. Receive the Prescription

When the patient qualifies and the provider approves treatment, the prescription is sent to a partner pharmacy for preparation and fulfilment.

4. Begin the Treatment Plan

The medication is shipped with instructions for dosing, injection and storage. The program also advertises ongoing access to its support team.

What Is Included?

The displayed membership price includes:

• Medical evaluation and clinical oversight
• Prescription processing when approved
• Compounded medication
• Ongoing support and check-ins
• Shipping to eligible US addresses
• Dose-related program management

Insurance is not required. The terms identify the service as cash-pay care, meaning patients are financially responsible for program charges.

Potential Benefits

• Provide convenient access to clinician-guided weight-management care.
• Designed to support appetite management when medication is appropriate.
• Provides once-weekly injectable options under a prescription.
• Includes medical review and ongoing program support.
• Contains medication and shipping within the displayed program price.

A specific amount of weight loss cannot be guaranteed. Individual response, tolerance and treatment duration vary.

Important Limitations

• Completing the assessment does not guarantee that a prescription will be issued.
• Medication concentration, appearance, instructions and dispensing pharmacy may vary.
• The programs automatically renew unless cancelled according to the terms.
• Orders generally become non-refundable once the initial medical intake is submitted.
• The telehealth service does not provide emergency medical care.

How to Use the Medication?

• Use the medication only after approval and prescription by the treating clinician.
• Administer the injection once weekly on the schedule provided with the prescription.
• Measure the exact prescribed amount using the instructions for the concentration supplied.
• Do not copy a dose from another patient, website or branded product.
• Follow the dispensing pharmacy’s refrigeration, storage and handling directions.
• Contact the care team before changing the dose, restarting after missed doses or stopping treatment.
• Do not combine it with another GLP-1 medication unless specifically instructed by the prescriber.

Compounded injectable products may come in different concentrations.

Warnings and Precautions

• Do not use medication that was prescribed for another person.
• Tell the provider about all prescriptions, supplements, allergies and medical conditions.
• Discuss any personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
• Inform the clinician about pancreatitis, gallbladder disease, kidney problems or severe digestive conditions.
• People using insulin or a sulfonylurea may need additional blood-glucose monitoring.
• Prescription weight-loss medication should not be used during pregnancy.
• Tell medical professionals about treatment before surgery or procedures involving anaesthesia.
• Seek advice for persistent vomiting, severe diarrhoea or difficulty maintaining hydration.
• Obtain emergency care for severe abdominal pain, breathing difficulty, facial swelling, fainting or a serious allergic reaction.

Approved semaglutide and tirzepatide products carry important warnings and precautions. A clinician must assess how those risks apply to the individual and the prescribed compounded formulation.

Possible Side Effects and Interactions

Common effects associated with GLP-1 and GIP/GLP-1 medicines include nausea, vomiting, diarrhoea, constipation, stomach discomfort and reduced appetite. Symptoms may be more noticeable after starting treatment or increasing the dose.

Serious concerns can include pancreatitis, gallbladder problems, dehydration-related kidney injury, severe digestive symptoms, allergic reactions and low blood sugar when combined with certain diabetes medicines. Compounded-product dosing mistakes may increase these risks. Patients should contact their clinician or pharmacist about persistent or severe symptoms.

Compounded Medication and Quality Information

Trinity Meds operates as a telehealth and program platform rather than the manufacturer of the compounded medication. Medical care is provided through OpenLoop-affiliated clinicians.

Compounded drugs do not undergo FDA premarket review for safety, effectiveness or manufacturing quality. The FDA advises that compounded medicines should generally be used when a patient’s medical needs cannot be met by an available FDA-approved product.

Before using a delivered vial, confirm:

• The patient’s name and prescription details
• The dispensing pharmacy
• Medication name and concentration
• Prescribed dose and syringe measurement
• Storage temperature
• Beyond-use date
• Seal and packaging condition
• Appearance of the medication

Contact the pharmacy or care team before injecting medication that appears damaged, discoloured, improperly stored or inconsistent with the accompanying instructions.

Pros

• Fully online assessment and clinician review
• Once-weekly medication options
• Program price includes medication and shipping
• No insurance requirement
• Service offered across all 50 US states
• Several treatment-duration options available

Cons

• A prescription is not guaranteed after payment.
• Plans renew automatically unless cancelled.
• Most processed medication orders are non-refundable.
• Exact formulation and concentration may vary by pharmacy.
• Injectable vials may create a risk of measurement errors.

Pricing and Cancellation Policy

Current promotional prices vary by medication and selected program length. The fees include medical oversight, medication, support and standard shipping.

Compounded Semaglutide Pricing

Compounded Tirzepatide Pricing

The limited promotional prices and states that the offer ends July 30, 2026. Customers should verify the final payment amount and billing schedule before completing checkout.

Refund and Cancellation Terms

The plans are subscriptions that renew automatically. The terms state that cancellation should be submitted at least 48 hours before the monthly processing date to prevent another charge.

Once the initial medical intake is submitted, the order is generally considered in process and non-refundable. A refund may be issued when the provider finds the patient medically ineligible or when Trinity Meds confirms a billing error. Written refund requests must be submitted within 28 days of payment.

Cancelling stops future recurring charges but does not normally refund a medication order that has already entered processing. Prescription medication cannot be cancelled after dispatch.

Pricing and availability were checked on July 27, 2026, and may change on the official website.

Pharmacist Note

Confirm the exact concentration, prescribed dose and syringe measurement before every injection. Compounded GLP-1 products can differ between pharmacies. Review diabetes medicines, pregnancy plans, digestive conditions and overlapping GLP-1 treatments with the prescriber or pharmacist before beginning therapy.

FAQs

1.What type of service is Trinity Meds?

Trinity Meds is an online weight-management platform connecting adults with licensed clinicians. It offers medical evaluation, prescription processing, compounded medication programs, ongoing support and home shipping when treatment is approved.

2.Which medications does the program currently offer?

The website lists compounded semaglutide and compounded tirzepatide injections. A licensed provider selects the appropriate option and dosing plan after reviewing the patient’s medical information.

3.How often is the medication taken?

Both displayed medication programs use a once-weekly subcutaneous injection. The exact concentration, syringe measurement and dose schedule depend on the prescription and instructions from the dispensing pharmacy.

4.Is everyone who completes the assessment approved?

No. Completing the assessment or paying for the program does not guarantee a prescription. An affiliated clinician has sole discretion to decide whether treatment is medically appropriate.

5.Can a Trinity Meds subscription be cancelled?

Yes. Cancellation prevents future renewal charges when completed within the required timeframe. Orders already approved, processed or shipped generally cannot be cancelled for a refund.

Medical Disclaimer

This content provides general information about an online prescription service and does not replace medical advice. Compounded medications are not FDA-approved or reviewed before marketing for safety, effectiveness or quality. Treatment requires an individual evaluation and prescription from a licensed healthcare professional. Call 911 or seek emergency care for serious symptoms.

Sources and Program Review Information

• Official Trinity Meds program, pricing and pharmacy information. (Trinity Meds)
• Official refund and cancellation policy. (Trinity Meds)
• Official terms governing subscriptions and medical services. (Trinity Meds)
• Official telehealth and compounded-medication consent. (Trinity Meds)
• FDA information about compounded medicines. (U.S. Food and Drug Administration)
• FDA concerns about compounded semaglutide and tirzepatide. (U.S. Food and Drug Administration)
• Current semaglutide prescribing information. (DailyMed)
• Current tirzepatide safety information. (MedlinePlus)
• Information checked: July 27, 2026